The Impact of Type 2 Diabetes on Peripheral and Cerebral Hemodynamic Responses to Active Stand.
Active stand
Cerebral perfusion
Functional regression
Orthostasis
Type 2 diabetes
Journal
The journals of gerontology. Series A, Biological sciences and medical sciences
ISSN: 1758-535X
Titre abrégé: J Gerontol A Biol Sci Med Sci
Pays: United States
ID NLM: 9502837
Informations de publication
Date de publication:
01 May 2024
01 May 2024
Historique:
received:
20
09
2023
medline:
19
4
2024
pubmed:
4
3
2024
entrez:
4
3
2024
Statut:
ppublish
Résumé
Although type 2 diabetes mellitus (T2DM) is an established risk factor for cognitive impairment, the underlying mechanisms remain poorly explored. One potential mechanism may be through effects of T2DM on cerebral perfusion. The current study hypothesized that T2DM is associated with altered peripheral and central hemodynamic responses to orthostasis, which may in turn be associated with cognitive impairment in T2DM. A novel use of function-on-scalar regression, which allows the entire hemodynamic response curve to be modeled, was employed to assess the association between T2DM and hemodynamic responses to orthostasis. Logistic regression was used to assess the relationship between tissue saturation index (TSI), T2DM, and cognitive impairment. All analyses used cross-sectional data from Wave 3 of The Irish Longitudinal Study on Ageing (TILDA). Of 2 984 older adults (aged 64.3 ± 8.0; 55% female), 189 (6.3%) had T2DM. T2DM was associated with many features that are indicative of autonomic dysfunction including a blunted peak heart rate and lower diastolic blood pressure. T2DM was associated with reduced TSI and also with greater odds of impaired performance on the Montreal Cognitive Assessment (odds ratio [OR]: 1.62; confidence interval [CI: 1.07, 2.56]; p = .019). Greater TSI was associated with lower odds of impaired performance (OR: 0.90, CI [0.81-0.99]; p = .047). T2DM was associated with impaired peripheral and cerebral hemodynamic responses to active stand. Both T2DM and reduced cerebral perfusion were associated with impaired cognitive performance. Altered cerebral perfusion may represent an important mechanism linking T2DM and adverse brain health outcomes in older adults.
Sections du résumé
BACKGROUND
BACKGROUND
Although type 2 diabetes mellitus (T2DM) is an established risk factor for cognitive impairment, the underlying mechanisms remain poorly explored. One potential mechanism may be through effects of T2DM on cerebral perfusion. The current study hypothesized that T2DM is associated with altered peripheral and central hemodynamic responses to orthostasis, which may in turn be associated with cognitive impairment in T2DM.
METHODS
METHODS
A novel use of function-on-scalar regression, which allows the entire hemodynamic response curve to be modeled, was employed to assess the association between T2DM and hemodynamic responses to orthostasis. Logistic regression was used to assess the relationship between tissue saturation index (TSI), T2DM, and cognitive impairment. All analyses used cross-sectional data from Wave 3 of The Irish Longitudinal Study on Ageing (TILDA).
RESULTS
RESULTS
Of 2 984 older adults (aged 64.3 ± 8.0; 55% female), 189 (6.3%) had T2DM. T2DM was associated with many features that are indicative of autonomic dysfunction including a blunted peak heart rate and lower diastolic blood pressure. T2DM was associated with reduced TSI and also with greater odds of impaired performance on the Montreal Cognitive Assessment (odds ratio [OR]: 1.62; confidence interval [CI: 1.07, 2.56]; p = .019). Greater TSI was associated with lower odds of impaired performance (OR: 0.90, CI [0.81-0.99]; p = .047).
CONCLUSIONS
CONCLUSIONS
T2DM was associated with impaired peripheral and cerebral hemodynamic responses to active stand. Both T2DM and reduced cerebral perfusion were associated with impaired cognitive performance. Altered cerebral perfusion may represent an important mechanism linking T2DM and adverse brain health outcomes in older adults.
Identifiants
pubmed: 38436476
pii: 7618536
doi: 10.1093/gerona/glae073
pmc: PMC11025558
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Science Foundation Ireland
ID : 18/FRL/6188
Pays : Ireland
Organisme : Health Research Board
Pays : Ireland
Organisme : Health Research Board
ID : 203930/B/16/Z
Pays : Ireland
Organisme : Health Research Board
ID : ILP-HSR-2017-021
Pays : Ireland
Organisme : Wellcome Trust
Pays : United Kingdom
Informations de copyright
© The Author(s) 2024. Published by Oxford University Press on behalf of The Gerontological Society of America.
Références
Circulation. 2014 Nov 11;130(20):1780-9
pubmed: 25278101
Yale J Biol Med. 2016 Mar 24;89(1):59-71
pubmed: 27505017
J Diabetes Complications. 2016 Jan-Feb;30(1):67-71
pubmed: 26412028
J Gerontol A Biol Sci Med Sci. 2022 Jun 1;77(6):1216-1221
pubmed: 34331759
J Am Geriatr Soc. 2022 Jul;70(7):1973-1986
pubmed: 35535653
Brain Imaging Behav. 2017 Oct;11(5):1248-1257
pubmed: 27714551
Front Cardiovasc Med. 2019 Jan 22;6:1
pubmed: 30740396
Int J Epidemiol. 2018 Oct 1;47(5):1398-1398l
pubmed: 30124849
Diabetes Care. 2007 May;30(5):1193-9
pubmed: 17290035
Kidney Blood Press Res. 2021;46(5):574-580
pubmed: 34284392
J Neurol. 2018 Oct;265(10):2267-2276
pubmed: 30062523
J Am Heart Assoc. 2014 May 08;3(3):e000668
pubmed: 24811610
Stroke. 2001 Nov;32(11):2492-500
pubmed: 11692006
Sci Rep. 2016 Dec;6(1):10
pubmed: 27920431
Int J Biostat. 2010;6(1):Article 28
pubmed: 21969982
Ann Neurol. 2019 Nov;86(5):754-761
pubmed: 31397912
Front Neuroendocrinol. 2021 Jul;62:100916
pubmed: 33957174
Am J Med. 1991 Aug;91(2):179-85
pubmed: 1867243
Nat Rev Endocrinol. 2018 Oct;14(10):591-604
pubmed: 30022099
PLoS Med. 2016 Oct 11;13(10):e1002143
pubmed: 27727284
J Intern Med. 2017 Dec;282(6):468-483
pubmed: 28564488
Front Aging Neurosci. 2014 Jan 23;6:1
pubmed: 24478697
Diabetes Res. 1986 Jul;3(6):301-6
pubmed: 3530593
Front Aging Neurosci. 2018 Jan 19;10:1
pubmed: 29403371
J Cardiovasc Transl Res. 2012 Aug;5(4):463-78
pubmed: 22644723
Arch Gerontol Geriatr. 2020 Mar - Apr;87:103988
pubmed: 31775091
Front Hum Neurosci. 2020 Feb 11;14:1
pubmed: 32116598
Diabet Med. 2020 Aug;37(8):1299-1307
pubmed: 31770459
Europace. 2018 Sep 1;20(9):1535-1542
pubmed: 29036615
QJM. 2009 May;102(5):335-9
pubmed: 19273552
J Diabetes Complications. 2017 Feb;31(2):462-467
pubmed: 27431891
Physiol Meas. 2004 Aug;25(4):823-36
pubmed: 15382824
Circ Res. 2016 Aug 19;119(5):666-75
pubmed: 27330018
Physiol Rev. 2021 Oct 1;101(4):1487-1559
pubmed: 33769101
Hypertension. 2018 May;71(5):946-954
pubmed: 29632103
J Appl Physiol (1985). 2003 Mar;94(3):833-48
pubmed: 12571122
J Am Heart Assoc. 2018 Oct 2;7(19):e008976
pubmed: 30371298
Diabet Med. 2021 Jun;38(6):e14412
pubmed: 32997841
Br J Psychiatry. 2019 Apr;214(4):230-236
pubmed: 30606275
Cardiovasc Res. 1998 Jun;38(3):605-16
pubmed: 9747429
Circulation. 2006 Aug 15;114(7):630-6
pubmed: 16894039
Diabetes Care. 2009 Jan;32(1):69-74
pubmed: 18852335
J Diabetes Complications. 2016 Jan-Feb;30(1):5-6
pubmed: 26601788
Int J Cardiol. 2015 Sep 15;195:40-4
pubmed: 26022797
Diabetes Res Clin Pract. 2006 May;72(2):142-7
pubmed: 16325958
Lancet Diabetes Endocrinol. 2014 Mar;2(3):246-55
pubmed: 24622755
Diabetes Res Clin Pract. 2015 Dec;110(3):241-9
pubmed: 26520567